NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amped PCR

Amped PCR

Private
AberystwythHealthcare & Life Scienceshttps://www.ampedpcr.co.uk/

Last Round

Grant

May 9, 2025

Total Funding Raised

$876,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amped PCR is a biotechnology company that manufactures high-performance PCR reagents and develops PurifAI, an automated, deployable laboratory system for rapid pathogen detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Environmental Monitoring, Business Intelligence

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

qPCR reagentspathogen detectionmolecular diagnosticspoint-of-care testingPOCTambient-stable reagentsfood safety testingveterinary diagnosticsenvironmental monitoringOEM manufacturingwhite-label reagentslab-on-a-chipmicrobial intelligenceAI diagnosticsdecentralized testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amped PCR Comps

Public and private peers based on sector, stage, and business model.

Amped PCR comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amped PCR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 9, 2025
SeedDec 16, 2024
GrantOct 1, 2024
GrantJul 8, 2022

Amped PCR Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 2138% MoM, from 37 to 828.

  • Dec 3, 2025

    Added Scan.com Corporation, a healthcare technology SMB, as a customer.

Amped PCR Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amped PCR Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amped PCR's valuation, stock price, and market status.

Firmographic Details

HeadquartersAberystwyth
Employee Range2
Year Founded2020
Last FundingMay 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.